ERBB2 and breast cancer: Metabolomics has identified specific metabolic alterations between four intrinsic subtypes of breast cancer (luminal A and B, HER2-enriched (ER−, HER2+), and TNBC) [33], and between ER+ and ER− breast cancer tissue metabolomes [55].